Health-related quality of life (QOL) is becoming an increasingly important endpoint in cancer clinical trials.
Giuseppe Lombardi, MD, PhD
Advertisement
Articles by Giuseppe Lombardi, MD, PhD
Advertisement
Latest Updated Articles
Quality of Life Is an Important Endpoint in Cancer TrialsPublished: June 22nd 2019 | Updated:
Advertisement
Advertisement
Trending on Oncology Nursing News
1
FDA Approves Subcutaneous Daratumumab in High-Risk Smoldering Myeloma
2
Frontline Vaccine/Pembro Yields PFS Benefit in Advanced Melanoma
3
APP-Led Quality Assurance Group Is Feasible, Identifies Safety Events
4
What an Oncology APP Should Know About Exercise in Cancer Care
5
